NCT07034443 Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation
| NCT ID | NCT07034443 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cedars-Sinai Medical Center |
| Condition | Fecal Incontinence |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-08-01 |
| Primary Completion | 2027-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-08-01 with a primary completion date of 2027-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to evaluate functional outcomes in patients with Ulcerative Colitis and IBDU who have received an ileal pouch anal anastomosis (IPAA), commonly referred to as a J pouch, after treatment with the Emsella chair. We will specifically look at fecal incontinence and patient health related quality of life outcomes before, during and after course of treatment.
Eligibility Criteria
Inclusion Criteria: * Individuals 18 years old or older are included. * Patients who have a J pouch reconstruction due to Ulcerative Colitis or IBDU * Must be at least 1 year out from J pouch surgery * Have fecal incontinence Exclusion Criteria: * Any records flagged "break the glass" or "research opt out." * Pediatric Patients \<18 years of age * Did not receive a J pouch * Patients who received a J pouch for any other indication, including but not limited to Crohn's disease, familial adenosis polyposis * Have active pouchitis * Have an active fistula * If reclassified to de novo Crohn's after surgery * Have implanted metal devices or medical devices * Pregnant patients
Contact & Investigator
Karen Zaghiyan, MD
PRINCIPAL INVESTIGATOR
Cedar Sinai Medical Center
Frequently Asked Questions
Who can join the NCT07034443 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Fecal Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07034443 currently recruiting?
Yes, NCT07034443 is actively recruiting participants. Contact the research team at samara.spence@cshs.org for enrollment information.
Where is the NCT07034443 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT07034443 clinical trial?
NCT07034443 is sponsored by Cedars-Sinai Medical Center. The principal investigator is Karen Zaghiyan, MD at Cedar Sinai Medical Center. The trial plans to enroll 20 participants.